1. Biodegradable, bile salt microparticles for localized fat dissolution
- Author
-
Omolola Eniola-Adefeso, Kanakadurga Singer, Hanieh Safari, Mita Varghese, Emma R. Brannon, Nicholas Kaczorowski, and Michael L. Felder
- Subjects
chemistry.chemical_classification ,Drug ,0303 health sciences ,Multidisciplinary ,Lysis ,media_common.quotation_subject ,Localized fat ,technology, industry, and agriculture ,SciAdv r-articles ,Salt (chemistry) ,In vitro ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,chemistry ,In vivo ,parasitic diseases ,Biophysics ,Particle ,Health and Medicine ,Dissolution ,Research Articles ,Research Article ,030304 developmental biology ,media_common - Abstract
We describe a novel gold-templating method for fabricating stable, biodegradable, bile salt microparticles with controlled geometry., Bile acids are proposed as therapeutic agents for various diseases, including liver diseases and obesity. However, oral or subcutaneous administration of a solubilized version of these drugs has limited efficacy and imposes unwanted side effects. Here, we describe a gold-templating method for fabricating stable, bile salt—cholate or deoxycholate—microparticles. The gold ions’ reduction at the oil-water interface in a double emulsion solvent evaporation process enables a gold–bile salt interaction and the formation of bile salt particles. We demonstrate that composite microparticles release cholate/deoxycholate into solution via a surface erosion process. We illustrate these particles’ capability to lyse adipocytes, both in vitro and in vivo, with minimal side effects, contrary to the Food and Drug Administration–approved salt solution that leads to severe inflammation and ulceration. Overall, particle-based cholate/deoxycholate opens opportunities for localized delivery of these salts, improving efficacy while minimizing side effects associated with oral and subcutaneous use.
- Published
- 2020
- Full Text
- View/download PDF